Competing interests
FOX, EMD
A.W. Silk: grants/research support—Biohaven Pharmaceuticals, Replimune, Morphogenesis, Shattuck Laboratories, and Checkmate Pharmaceuticals; advisory board member—Bristol Myers Squibb, EMD Serono, Sanofi Genzyme, and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA; consultant/independent contractor—WorldCare Clinical. S.J. O’Day: grants/research support—Biothera, Bristol Myers Squibb, Exicure, ImaginAB, Genocea, Shattuck Labs, Ultimovacs, Vyriad, and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA; advisory board member—Bristol Myers Squibb, ImmunoSync, Biothera, Exicure, and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. H.L. Kaufman: employee—Ankyra Therapeutics; advisory board member—Castle Biosciences and Marengo Therapeutics. S. Fein: consultant/independent contractor—CNF Pharma, LLC, contracted to Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. C. Wu: former employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and stockholder in Merck & Co., Inc., Rahway, NJ, USA. L. Guerreiro: consultant/independent contractor—Practical Clinical Research Solutions Inc., contracted to Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. P.K. Bommareddy: employee—Replimune Inc. A. Zloza: grants/research support—Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA; advisory board member, consultant/independent contractor, and shareholder—PrimeVax Immuno-Oncology, Inc. B.A. Fox: employee—Earle A. Chiles Research Institute; grants/research support—NCI 5 R01 CA142779-09, Macrogenics, OncoSec, and Akoya; advisory board member—Akoya, AstraZeneca, Bristol Myers Squibb, Incyte, PrimeVax, Turnstone, UbiVac, and Ultivue; shareholder—PrimeVax, Turnstone, and UbiVac. Y. Ren: employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and stockholder in Merck & Co., Inc., Rahway, NJ, USA. D. Shafren: employee—ImmvirX Pty Ltd. M. Grose: consultant/independent contractor—contracted directly by Viralytics. J.M. Mehnert: grants/research support—Amgen, AstraZeneca, Bristol Myers Squibb, Novartis, Polynoma, Sanofi, EMD Serono, Immunocore, Incyte, Macrogenics, and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA; advisory board member—Array BioPharma, Bristol Myers Squibb, EMD Serono, and Sanofi/Regeneron; consultant/independent contractor—Amgen and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA; honorarium—EMD Serono and Pfizer. J. Bryan, J.T. Norrell, C. Imbergamo, D. Portal, E. Zambrano-Acosta, M. Palmeri, D. Medina, C. Ballesteros-Merino, and J.A. Vieth: nothing to disclose.